Dennis Cho
Compliance Officer bei TWIST BIOSCIENCE CORPORATION
Aktive Positionen von Dennis Cho
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
TWIST BIOSCIENCE CORPORATION | Compliance Officer | 27.09.2021 | - |
General Counsel | 27.09.2021 | - | |
Unternehmenssekretär | 27.09.2021 | - |
Karriereverlauf von Dennis Cho
Ehemalige bekannte Positionen von Dennis Cho
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SEAGEN INC. | Direktor/Vorstandsmitglied | 01.12.2019 | 01.01.2021 |
CELGENE | Direktor/Vorstandsmitglied | 01.10.2010 | 01.12.2019 |
CYTOMX THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
Image Entertainment, Inc.
Image Entertainment, Inc. Movies/EntertainmentConsumer Services Image Entertainment, Inc. distributes home entertainment programming on different formats and platforms. The company was founded in April 1975 and is headquartered in Woodland Hills, CA. | General Counsel | - | - |
Ausbildung von Dennis Cho
University of California, Berkeley | Graduate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Operativ
Director/Board Member | 2 |
General Counsel | 2 |
Compliance Officer | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
TWIST BIOSCIENCE CORPORATION | Health Technology |
CYTOMX THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Image Entertainment, Inc.
Image Entertainment, Inc. Movies/EntertainmentConsumer Services Image Entertainment, Inc. distributes home entertainment programming on different formats and platforms. The company was founded in April 1975 and is headquartered in Woodland Hills, CA. | Consumer Services |
Seagen Inc.
Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Börse
- Insiders
- Dennis Cho
- Erfahrung